Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

Abdool Karim, Salim; Naidoo, Kogieleum; Grobler, Anneke C.; Padayatchi, Nesri; Baxter, Cheryl; Gray, Andrew L.; Gengiah, Tanuja N.; Nair, Gonasagrie; Bamber, Sheila; Singh, Aarthi; Khan, Munira; Pienaar, Jacqueline; El-Sadr, Wafaa Mahmoud; Friedland, Gerald; Abdool Karim, Quarraisha

The rates of death are high among patients with coinfection with tuberculosis and the human immunodeficiency virus (HIV). The optimal timing for the initiation of antiretroviral therapy in relation to tuberculosis therapy remains controversial.


Also Published In

New England Journal of Medicine

More About This Work

Academic Units
Published Here
September 9, 2010